NetworkNewsBreaks

FridayAug 28, 2020 11:56 am

NetworkNewsBreaks – Esports Entertainment Group Inc. (NASDAQ: GMBL) and Allied Esports Entertainment Inc. (NASDAQ: AESE) to Launch Inaugural VIE.gg CS:GO Legend Series Tournament

Esports Entertainment (NASDAQ: GMBL, GMBLW), a licensed online gambling company with a focus on esports wagering and 18+ gaming, has entered into a licensing and sponsorship agreement with Allied Esports, a subsidiary of Allied Esports Entertainment (NASDAQ: AESE), for the inaugural VIE.gg Counter-Strike: Global Offensive (“CS:GO”) Legend Series tournament beginning Monday, August 31, 2020. According to the update, the VIE.gg CS:GO Legend Series will feature 12 teams from multiple European countries competing online for €50,000 in total prize money. The 5v5 tournament will be offered to VIE.gg platform customers and produced by Allied Esports from its HyperX Esports Studio in…

Continue Reading

FridayAug 28, 2020 11:37 am

NetworkNewsBreaks – Jerrick Media Holdings Inc. (JMDAD) Intends to Rebrand, Uplist to Nasdaq Capital Market

Jerrick Media Holdings (OTCQB: JMDAD) CEO Jeremy Frommer recently provided an update regarding the company’s stock and planned rebranding from Jerrick to Creatd. On August 17, 2020, Jerrick effectuated a 1-for-3 reverse stock split of its issued and outstanding shares of common stock (http://nnw.fm/OHkD6). Following the reverse split, the company's common stock began trading on a split-adjusted basis under the temporary symbol "JMDAD" on the OTCMarkets. Upon the completion of Jerrick’s anticipated uplisting, the company will begin trading on the Nasdaq Capital Market under the new stock symbol “CRTD”. For more information, visit the company’s website at www.Jerrick.media. About Jerrick Media…

Continue Reading

FridayAug 28, 2020 11:15 am

NetworkNewsBreaks – Wrap Technologies, Inc. (NASDAQ: WRTC) to Present to Live Virtual Audience at The LD 500

Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, today announced its plans to present at the LD 500 investor conference, scheduled to take place from Sept. 1-4, 2020. According to the update, Wrap Technologies' management will be presenting to a live virtual audience at 10:40 a.m. PT / 1:40 p.m. ET. on Thursday, Sept. 3, and holding one-on-one virtual meetings with institutional investors and analysts throughout the day. The presentation will be webcast live and made available for replay by visiting http://nnw.fm/mGXWx, with a replay of the presentation also available on the company’s website. Interested parties may register…

Continue Reading

FridayAug 28, 2020 10:59 am

NetworkNewsBreaks – Sustainable Green Team Ltd. (SGTM) Deploys Team to Assess Hurricane Laura Damages, Strategize Recovery

Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, today announced that its wholly owned subsidiary, National Storm Recovery LLC (“NSR”), has deployed a team to assess damages from Hurricane Laura and to strategize recovery through its national partnerships with governing agencies. NSR’s team, with expertise in dangerous tree removal and debris hauling and management, deploys its mobile command center to designated sites to asses storms and strategize with its national partners, which include government agencies, prime contractors and subcontractors. Hurricane Laura made landfall Thursday morning as a “ferocious Category 4…

Continue Reading

FridayAug 28, 2020 10:17 am

NetworkNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Issues Update, Confirms Expansion of Product Innovation Pipeline

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium, certified-organic cannabis, today provided an update on the progress of its corporate initiatives. Among other highlights, the update covered the company’s successful May launch, in Quebec, of its mainstream brand, Highly Dutch. Given strong sales, TGOD intends to expand to the balance of Canada in late September once it has built sufficient inventory to provide consistent supply to the market. In addition, the update discussed TGOD’s introduction of multiple 2.0 products during the second quarter, including RIPPLE dissolvables, teas and vapes. Based on the popularity of…

Continue Reading

FridayAug 28, 2020 9:38 am

NetworkNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Announces Second Eye-Net Pilot with Japanese Multinational Company

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced that its wholly owned subsidiary, Eye-Net Mobile Ltd., will start a pilot project with a multibillion, multinational Japanese electronics company to test its Eye-Net(TM) Protect cellular-based vehicle-to-everything (“V2X”) accident prevention solution. This is the second pilot project Foresight announced this month, following first with a multibillion global Japanese technology company to test Eye-Net Mobile's solution. “This second pilot project is a vote of confidence from another Japanese company that reinforces our market penetration strategy, targeting the smart devices and services market, including dashcams, head-up displays,…

Continue Reading

ThursdayAug 27, 2020 3:02 pm

NetworkNewsBreaks – Processa Pharmaceuticals Inc. (PCSA) Enters Exclusive Agreement to Expand Pipeline, Oncology Involvement

Processa Pharmaceuticals (OTCQB: PCSA), today announced its entry into a contingent precedent exclusive licensing agreement with Elion Oncology Inc. to develop, manufacture and commercialize eniluracil (“PCS6422”) globally. According to the update, PCS6422 is an oral drug designed to be administered with fluoropyrimidine cancer drugs (i.e., “capecitabine,” “5-FU”) in order to decrease their breakdown to inactive metabolites or metabolites known to cause unwanted side effects and interfere with the anticancer activity. “Having worked on 5-FU and other cancer agents in the past, adding PCS6422 to our pipeline and expanding our involvement in oncology was an easy decision given the significant impact…

Continue Reading

ThursdayAug 27, 2020 2:35 pm

NetworkNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) to Offer Esketamine for Treatment of Adults with MDD at Flagship Clinic

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), today announced that it is expanding its rapid-onset treatment service for major depressive disorder (“MDD”). According to the update, Champignon will offer esketamine for the treatment of adults with MDD at its flagship clinic, the Canadian Rapid Treatment Centre of Excellence (“CRTCE”), starting in September 2020. Declared a breakthrough treatment for depression by the US Food and Drug Administration (“FDA”), esketamine was approved by Health Canada for the treatment of MDD in May 2020. “The availability of esketamine at the CRTCE provides tremendous opportunity for adults across Canada affected by treatment-resistant depression…

Continue Reading

ThursdayAug 27, 2020 1:03 pm

NetworkNewsBreaks – ISW Holdings Inc. (ISWH) Bit5ive Partnership Is ‘Big Deal for ISWH Shares’

ISW Holdings (OTC: ISWH), a global brand-management portfolio company with diverse partnerships, is entering a promising new space just in time for the revolution in turnkey crypto-mining solutions (http://nnw.fm/c2u6D). A recent article discussing this covers a TradingView report that highlights the company’s opportunity and optimal timing through a recent collaboration it deems a “big deal for ISWH shares.” The piece reads, “ISW Holdings Inc. has entered the crypto-mining equipment industry by virtue of its recent joint venture partnership with Bit5ive LLC, a global top player in the space developing, running and selling what are known as ‘turnkey mining solutions.’ This…

Continue Reading

ThursdayAug 27, 2020 12:41 pm

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) and TumorGenesis Advancing Path Toward Patient-Specific Treatments

Predictive Oncology (NASDAQ: POAI), together with its TumorGenesis subsidiary, has achieved significant breakthroughs in applying data and artificial intelligence (“AI”) to personalized medicine and drug discovery. Earlier in June, TumorGenesis, which is developing a new rapid approach to growing tumors in the laboratory, sold its first order of unique ovarian cancer cell culture media to a New England-based university carrying out research within the sector (http://nnw.fm/yv6Qj). A recent article discussing POAI and TumorGenesis reads, “Predictive Oncology focuses on building AI-driven predictive models of tumor drug response and outcomes from its database of drug-response and genomic profiles gathered from more than…

Continue Reading